The Straxon Group executes assignments for In vitro Diagnostics (IVD), Clinical Diagnostic organisations as well as companies active in the companion diagnostics field. The diagnostic industry and the companies with its main diagnostic platforms are constantly affected by new developments of the relevant technologies (molecular, nanotech, etc.) but as well by the developments in the therapeutic (bio)pharmaceutical and medical device fields.

 

The clinical diagnostic market can be described as being more concentrated, as a limited number of market leaders have high market shares.

Consultants of the Straxon Group understand very well how the relevant developments in the diagnostic fields affect the search assignments.

 

Recent assignments are shown when clicking on each position.